Anisodine hydrobromide drop pill and preparing method thereof

A technology of anisodine hydrobromide and dropping pills is applied in the directions of pill delivery, antidote, antipyretic and the like, and can solve the problems affecting the therapeutic effect of anisodine hydrobromide and the disintegration time of anisodine hydrobromide tablets. It is easy to carry and take, has good compliance, and reduces the amount of excipients.
CN1528304AInactive Publication Date: 2004-09-15HONGYI SCI & TECH CO LTD NANCHANG

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
HONGYI SCI & TECH CO LTD NANCHANG
Publication Date
2004-09-15
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The present invention utilizes ultramicropulverization and dripping pill preparation production process to make aniosidine hydrobromide dripping pills, and can attain the goal of raising disintegration and dissolution speed, quickly obtaining therapeutic effect, raising stability of medicine, reducing dose of auxiliary material, reducing production cost and convenient administration. Said pill not noly can be sucket, but also can be swallowed, and its compliance is good.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a pharmaceutical preparation and a preparation method thereof, in particular to anisodine hydrobromide dripping pills and a preparation method thereof. Background technique

[0002] Anisodine Hydromide (Anisodine Hydromide) has obvious central anticholinergic effect, it competes with acetylcholine at the M choline receptor site, prevents the combination of acetylcholine and M choline receptor, thereby blocking the transmission of nerve impulses and achieving interference Physiological functions resulting from cholinergic neurotransmission. Can relieve vasospasm, improve microcirculation, anti-tremor, antispasmodic, antiasthma, inhibit glandular secretion, mydriasis and resist organophosphate pesticide poisoning. The intensity of action is weaker than that of atropine, but the toxicity is small. Only tablets are currently on the market, which are clinically used for the treatment of migraine, vascular headache, retinal vasospa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More